Inhibitory effects of Dioscin on atherosclerosis and foam cell formation in hyperlipidemia rats

Aluganti Narasimhulu C, Fernandez-Ruiz I, Selvarajan K, Jiang X, Sengupta B, Riad A, Parthasarathy S (2016) Atherosclerosis—do we know enough already to prevent it? Curr Opin Pharmacol 27:92–102 Bhaskar V, Yin J, Mirza AM, Phan D, Vanegas S, Issafras H, Michelson K, Hunter JJ, Kantak SS (2011) Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice. Atherosclerosis 216:313–320 Chase AJ, Bond M, Crook MF, Newby AC (2002) Role of nuclear factor-kappa B activation in metalloproteinase-1, -3, and -9 secretion by human macrophages in vitro and rabbit foam cells produced in vivo. Arterioscler Thromb Vasc Biol 22:765–771 Deepa PR, Varalakshmi P (2005) Atheroprotective effect of exogenous heparin-derivative treatment on the aortic disturbances and lipoprotein oxidation in hypercholesterolemic diet fed rats. Clin Chim Acta 355:119–130 Feng J, Gao J, Li Y, Yang Y, Dang L, Ye Y, Deng J, Li A (2014) BMP4 enhances foam cell formation by BMPR-2/Smad1/5/8 signaling. Int J Mol Sci 15:5536–5552 Glass CK, Witztum JL (2001) Atherosclerosis. the road ahead. Cell 104:503–516 Goyal T, Mitra S, Khaidakov M, Wang X, Singla S, Ding Z, Liu S, Mehta JL (2012) Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis. Curr Atheroscler Rep. 2012 Jan 29. [Epub ahead of print] PMID: 22286193 Hashizume M, Mihara M (2012) Atherogenic effects of TNF-α and IL-6 via up-regulation of scavenger receptors. Cytokine 58:424–430 Kanters E, Pasparakis M, Gijbels MJ et al (2003) Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J Clin Invest 112:1176–1185 Kanters E, Gijbels MJ, van der Made I, Vergouwe MN, Heeringa P, Kraal G, Hofker MH, de Winther MP (2004) Hematopoietic NF-kappaB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype. Blood 103:934–940 Kataoka H, Kume N, Miyamoto S et al (1999) Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 99:3110–3117 Li L, Sawamura T, Renier G (2004) Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation. Circ Res 94:892–901 Li K, Tang Y, Fawcett JP, Gu J, Zhong D (2005) Characterization of the pharmacokinetics of dioscin in rat. Steroids 70:525–530 Li HQ, Zhang Q, Chen L et al (2015) Captopril inhibits maturation of dendritic cells and maintains their tolerogenic property in atherosclerotic rats. Int Immunopharmacol 28:715–723 Lin YW, Liu PS, Adhikari N, Hall JL, Wei LN (2015) RIP140 contributes to foam cell formation and atherosclerosis by regulating cholesterol homeostasis in macrophages. J Mol Cell Cardiol 79:287–294 Liu M, Xu L, Yin L et al (2015a) Potent effects of dioscin against obesity in mice. Sci Rep 5:7973 Liu M, Xu Y, Han X et al (2015b) Dioscin alleviates alcoholic liver fibrosis by attenuating hepatic stellate cell activation via the TLR4/MyD88/NF-κB signaling pathway. Sci Rep 5:18038 Lu X (2016) Impact of macrophages in atherosclerosis. Curr Med Chem 23:1926–1937 Lu B, Xu Y, Xu L, Cong X, Yin L, Li H, Peng J (2012) Mechanism investigation of dioscin against CCl4-induced acute liver damage in mice. Environ Toxicol Pharmacol 34:127–135 Ma M, Song L, Yan H et al (2016) Low dose tunicamycin enhances atherosclerotic plaque stability by inducing autophagy. Biochem Pharmacol 100:51–60 Martín-Fuentes P, Civeira F, Recalde D, García-Otín AL, Jarauta E, Marzo I, Cenarro A (2007) Individual variation of scavenger receptor expression in human macrophages with oxidized low-density lipoprotein is associated with a differential inflammatory response. J Immunol 179:3242–3248 Mehta JL, Sanada N, Hu CP et al (2007) Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res 100:1634–1642 Moore KJ, Tabas I (2011) Macrophages in the pathogenesis of atherosclerosis. Cell 145:341–355 Murawska-Cialowicz E, Januszewska L, Zuwala-Jagiello J et al (2008) Melatonin decreases homocysteine level in blood of rats. J Physiol Pharmacol 59:717–729 Noa M, Mas R (2005) Protective effect of policosanol on atherosclerotic plaque on aortas in monkeys. Arch Med Res 36:441–447 Pamukcu B, Lip GY, Shantsila E (2011) The nuclear factor–kappa B pathway in atherosclerosis: a potential therapeutic target for atherothrombotic vascular disease. Thromb Res 128:117–123 Pan CH, Tsai CH, Liu FC, Fan MJ, Sheu MJ, Hsieh WT, Wu CH (2013) Influence of different particle processing on hypocholesterolemic and antiatherogenic activities of yam (Dioscorea pseudojaponica) in cholesterol-fed rabbit model. J Sci Food Agric 93:1278–1283 Panel AP (2006) Reducing residual cardiovascular risk: the relevance of raising high-density lipoprotein cholesterol in patients on cholesterol-lowering treatment. Diabetes Vasc Dis Resn 3:S1–S12 Papa S, Bubici C, Zazzeroni F, Franzoso G (2009) Mechanisms of liver disease: cross-talk between the NF-kappaB and JNK pathways. Biol Chem 390:965–976 Pirillo A, Norata GD, Catapano AL (2013) LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm 2013:152786 Poudel B, Lim SW, Ki HH, Nepali S, Lee YM, Kim DK (2014) Dioscin inhibits adipogenesis through the AMPK/MAPK pathway in 3T3-L1 cells and modulates fat accumulation in obese mice. Int J Mol Med 34:1401–1408 Qi M, Zheng L, Qi Y et al (2015) Dioscin attenuates renal ischemia/reperfusion injury by inhibiting the TLR4/MyD88 signaling pathway via up-regulation of HSP70. Pharmacol Res 100:341–352 Qu X, Zhai Z, Liu X et al (2014) Dioscin inhibits osteoclast differentiation and bone resorption though down-regulating the Akt signaling cascades. Biochem Biophys Res Commun 443:658–665 Robbesyn F, Salvayre R, Negre-Salvayre A (2004) Dual role of oxidized LDL on the NF-kappaB signaling pathway. Free Radic Res 38:541–551 Rodríguez C, Alcudia JF, Martínez-González J, Raposo B, Navarro MA, Badimon L (2008) Lysyl oxidase (LOX) down-regulation by TNFalpha: a new mechanism underlying TNFalpha-induced endothelial dysfunction. Atherosclerosis 196:558–564 Scott J (2004) Pathophysiology and biochemistry of cardiovascular disease. Curr Opin Genet Dev 14:271–279 Shapiro MD, Fazio S (2016) From lipids to inflammation: new approaches to reducing atherosclerotic risk. Circ Res 118:732–749 Shepherd J, Cobbe SM, Ford I et al; West of Scotland Coronary Prevention Study Group (2004) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia, 1995. Atheroscler Suppl 5:91–97 Tao X, Wan X, Xu Y et al (2014) Dioscin attenuates hepatic ischemia-reperfusion injury in rats through inhibition of oxidative-nitrative stress, inflammation and apoptosis. Transplantation 98:604–611 Tao X, Sun X, Yin L et al (2015) Dioscin ameliorates cerebral ischemia/reperfusion injury through the downregulation of TLR4 signaling via HMGB-1 inhibition. Free Radic Biol Med 84:103–115 van der Vorst EP, Döring Y, Weber C (2015) Chemokines and their receptors in Atherosclerosis. J Mol Med (Berl) 93:963–971 Wang L, Meng Q, Wang C et al (2013) Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562/adriamycin cells by down- regulating MDR1 via a mechanism involving NF-κB signaling inhibition. J Nat Prod 76:909–914 Wang H, Liu Y, Zhu L et al (2014) 17β-estradiol promotes cholesterol efflux from vascular smooth muscle cells through a liver X receptor α-dependent pathway. Int J Mol Med 33:550–558 White SJ, Sala-Newby GB, Newby AC (2011) Overexpression of scavenger receptor LOX-1 in endothelial cells promotes atherogenesis in the ApoE(-/-) mouse model. Cardiovasc Pathol 20:369–373 Wong MC, de Zhang X, Wang HH (2015) Rapid emergence of atherosclerosis in Asia: a systematic review of coronary atherosclerotic heart disease epidemiology and implications for prevention and control strategies. Curr Opin Lipidol 26:257–269 Wu S, Xu H, Peng J, Wang C, Jin Y, Liu K, Sun H, Qin J (2015) Potent anti-inflammatory effect of dioscin mediated by suppression of TNF-α-induced VCAM-1, ICAM-1and EL expression via the NF-κB pathway. Biochimie 110:62–72 Xia X, Li Y, Su Q, Huang Z, Shen Y, Li W, Yu C (2015) Inhibitory effects of Mycoepoxydiene on macrophage foam cell formation and atherosclerosis in ApoE-deficient mice. Cell Biosci 5:23 Xu S, Ogura S, Chen J, Little PJ, Moss J, Liu P (2013) LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cell Mol Life Sci 70:2859–2872 Xu T, Zheng L, Xu L, Yin L, Qi Y, Xu Y, Han X, Peng J (2014a) Protective effects of dioscin against alcohol-induced liver injury. Arch Toxicol 88:739–753 Xu Y, Kong X, Zhou H, Zhang X, Liu J, Yan J, Xie H, Xie Y (2014b) oxLDL/β2GPI/anti-β2GPI complex induced macrophage differentiation to foam cell involving TLR4/NF-kappa B signal transduction pathway. Thromb Res 134:384–392 Yang RX, Huang SY, Yan FF, Lu XT, Xing YF, Liu Y, Liu YF, Zhao YX (2010) Danshensu protects vascular endothelia in a rat model of hyperhomocysteinemia. Acta Pharmacol Sin 31:1395–1400 Zhang M, Wu JF, Chen WJ et al (2014) MicroRNA- 27a/b regulates cellular cholesterol efflux, influx and esterification/hydrolysis in THP-1 macrophages. Atherosclerosis 234:54–64 Zhang N, Lei J, Lei H, Ruan X, Liu Q, Chen Y, Huang W (2015) MicroRNA-101 overexpression by IL-6 and TNF-α inhibits cholesterol efflux by suppressing ATP-binding cassette transporter A1 expression. Exp Cell Res 336:33–42 Zhao X, Xu L, Zheng L, Yin L, Qi Y, Han X, Xu Y, Peng J (2016) Potent effects of dioscin against gastric cancer in vitro and in vivo. Phytomedicine 23:274–282 Zhou F, Pan Y, Huang Z, Jia Y, Zhao X, Chen Y, Diao J, Wan Q, Cui X (2013) Visfatin induces cholesterol accumulation in macrophages through up-regulation of scavenger receptor-A and CD36. Cell Stress Chaperones 18:643–652